David Parr

5PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersRespiratory diseasesCell physiologyMajor global burdens of diseaseOther European languages
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 03, 2025
Modification of the course of disease progression in idiopathic pulmonary fibrosis by pirfenidone: evidence of the potential for disease reversal.

Alexander Herrmann, David Parr

|Feb 11, 2025
Hypervitaminosis B12: an indicator of potential significant morbidity.

Muzammil Munnawar Saeed, David Parr

|Nov 25, 2024
Quantitative BAL: a suitable method for the assessment of epithelial lining fluid in alpha-1 antitrypsin deficiency?

David G Parr

|Jul 23, 2024
Antitrypsin deficiency: still more to learn about the lung after 60 years.

Robert A Stockley, David G Parr

|Mar 30, 2023
Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry.

Marc Miravitlles, Alice M Turner, María Torres-Duran

Pageof 1

Frequent Collaborators

1 joint publications

Marc Miravitlles

1 joint publications

Alice M Turner

1 joint publications

José Luis López-Campos

1 joint publications

Jan Chlumsky